Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
23 rows where has_cryoEM = 1, has_known_aptamer = 1 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, alphafold_mean_pLDDT, aptamer_count_pubmed, opentargets_top_disease_name
surface_class 1
- A2_pm_peripheral · 23 ✖
has_structure 1
- 1 23
has_known_aptamer 1
- 1 · 23 ✖
has_cryoEM 1
- 1 · 23 ✖
has_activation_state_pdb_pair 1
- 0 23
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P01137 | TGFB1 | Transforming growth factor beta-1 proprotein | Tier 1 | 0.78 | 1 | A2_pm_peripheral | 20 | 79.56 | 1 | 0 | 1 | 4 | 38132522, 32370304, 16775010, 11856769 | 1 | Camurati-Engelmann disease | 0.7995305374459716 | ||
| Q9ULC3 | RAB23 | Ras-related protein Rab-23 | Tier 1.5 | 0.776 | 1 | A2_pm_peripheral | 6 | 79.56 | 1 | 0 | 1 | 1 | 23618401 | 1 | RAB23-related Carpenter syndrome | 0.7879955689930709 | ||
| Q92743 | HTRA1 | Serine protease HTRA1 | Tier 1 | 0.768 | 1 | A2_pm_peripheral | 18 | 83.25 | 1 | 0 | 1 | 1 | 31988066 | 1 | cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | 0.7611877816680132 | ||
| P35221 | CTNNA1 | Catenin alpha-1 | Tier 1 | 0.765 | 1 | A2_pm_peripheral | 10 | 82.94 | 1 | 0 | 1 | 2 | 40265971 | 1 | Butterfly-shaped pigment dystrophy | 0.7487735496199569 | ||
| P84077 | ARF1 | ADP-ribosylation factor 1 | Tier 1 | 0.755 | 1 | A2_pm_peripheral | 36 | 85.94 | 1 | 0 | 1 | 3 | 30965174, 11320245 | 1 | periventricular nodular heterotopia 8 | 0.7173626622431929 | ||
| Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Tier 1 | 0.749 | 1 | A2_pm_peripheral | 39 | 69.75 | 1 | 0 | 1 | 2 | 41290466, 35919280 | 1 | immunodeficiency 57 | 0.698121745966467 | ||
| P50148 | GNAQ | Guanine nucleotide-binding protein G(q) subunit alpha | Tier 1 | 0.748 | 1 | A2_pm_peripheral | 30 | 93.0 | 1 | 0 | 1 | 1 | 40015005 | 1 | Sturge-Weber syndrome | 0.6941111530708174 | ||
| O95786 | RIGI | Antiviral innate immune response receptor RIG-I | Tier 1 | 0.735 | 1 | A2_pm_peripheral | 44 | 85.19 | 1 | 0 | 1 | 6 | 34487794, 33253193, 32946572, 31600868, 26018150, 22127865 | 1 | Singleton-Merten dysplasia | 0.6485708110478319 | ||
| P23921 | RRM1 | Ribonucleoside-diphosphate reductase large subunit | Tier 1 | 0.724 | 1 | A2_pm_peripheral | 12 | 92.25 | 1 | 0 | 1 | 1 | 21955496 | 1 | non-small cell lung carcinoma | 0.6122881671315019 | ||
| P32121 | ARRB2 | Beta-arrestin-2 | Tier 1.5 | 0.719 | 1 | A2_pm_peripheral | 1 | 83.81 | 1 | 0 | 1 | 4 | 24736311, 40652239, 29054528 | 1 | cancer | 0.5962458729823639 | ||
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Tier 1 | 0.706 | 1 | A2_pm_peripheral | 21 | 98.12 | 1 | 0 | 1 | 11 | 39832592, 39429683, 35821507, 28131717, 26310631, 23215008, 37500700, 16115199 | 1 | neurodegenerative disease | 0.55307368855439 | ||
| P31948 | STIP1 | Stress-induced-phosphoprotein 1 | Tier 1.5 | 0.689 | 1 | A2_pm_peripheral | 8 | 89.75 | 1 | 0 | 1 | 7 | 41406518, 38012811, 34831332, 32614006, 27681499, 24654750, 24013070 | 1 | neurodegenerative disease | 0.4967711525222825 | ||
| P21980 | TGM2 | Protein-glutamine gamma-glutamyltransferase 2 | Tier 1.5 | 0.688 | 1 | A2_pm_peripheral | 17 | 92.88 | 1 | 0 | 1 | 1 | 35980938 | 1 | neurodegenerative disease | 0.49455272812698803 | ||
| P49327 | FASN | Fatty acid synthase | Tier 1 | 0.68 | 1 | A2_pm_peripheral | 34 | 85.44 | 1 | 0 | 1 | 1 | 41854184 | 1 | dengue disease | 0.46815584653391107 | ||
| P63098 | PPP3R1 | Calcineurin subunit B type 1 | Tier 1.5 | 0.673 | 1 | A2_pm_peripheral | 21 | 91.12 | 1 | 0 | 1 | 2 | 39263947 | 1 | Abnormality of the skeletal system | 0.44389060142742937 | ||
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Tier 1 | 0.661 | 1 | A2_pm_peripheral | 32 | 84.31 | 1 | 0 | 1 | 1 | 35921069 | 1 | multiple myeloma | 0.40496963397728575 | ||
| P06702 | S100A9 | Protein S100-A9 | Tier 1 | 0.651 | 1 | A2_pm_peripheral | 13 | 94.31 | 1 | 0 | 1 | 9 | 41924874, 41505229, 41477217, 40215752, 39317671, 37879125, 35724603, 33534888, 32478041 | 1 | inborn error of immunity | 0.36994943453938645 | ||
| P15104 | GLUL | Glutamine synthetase | Tier 1.5 | 0.622 | 1 | A2_pm_peripheral | 12 | 97.5 | 1 | 0 | 1 | 4 | 39533430, 30085248, 21282981 | 0 | congenital brain dysgenesis due to glutamine synthetase deficiency | 0.7733687702812198 | ||
| P10636 | MAPT | Microtubule-associated protein tau | Tier 1 | 0.618 | 1 | A2_pm_peripheral | 100 | 49.22 | 1 | 0 | 1 | 9 | 40380000, 39241336, 38585969, 38397086, 37003060, 31900535, 30004544, 29268187 | 0 | Pick disease | 0.7600399335134378 | ||
| P41159 | LEP | Leptin | Tier 1 | 0.606 | 1 | A2_pm_peripheral | 10 | 81.12 | 1 | 0 | 1 | 14 | 40330320, 40008515, 39263947, 37331044, 36508319, 36173490, 35884340, 34016094, 33650854, 32527800, 27530235, 26529285, 23232067, 20594164 | 0 | obesity due to congenital leptin deficiency | 0.7197450249224271 | ||
| P43351 | RAD52 | DNA repair protein RAD52 homolog | Tier 1 | 0.528 | 1 | A2_pm_peripheral | 11 | 69.62 | 1 | 0 | 1 | 6 | 37288783, 32945515, 31495919, 26784987, 24500205, 23836560 | 0 | Abnormality of the skeletal system | 0.45994164258033876 | ||
| O75182 | SIN3B | Paired amphipathic helix protein Sin3b | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 4 | 68.0 | 1 | 0 | 1 | 2 | 16914451 | 0 | syndromic intellectual disability | 0.37050380432141355 | ||
| P55089 | UCN | Urocortin | Tier 1.5 | 0.469 | 1 | A2_pm_peripheral | 6 | 68.25 | 1 | 0 | 1 | 3 | 30221506, 26488412, 23248006 | 0 | neurodegenerative disease | 0.26311734927710556 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;